Cosy Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 16-11-2024
- Paid Up Capital ₹ 8.38 M
as on 16-11-2024
- Company Age 38 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 19.50 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.87 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit -62.22%
(FY 2023)
- Ebitda -135.81%
(FY 2023)
- Net Worth -0.14%
(FY 2023)
- Total Assets -0.11%
(FY 2023)
About Cosy Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 8.38 M.
The company currently has active open charges totaling ₹19.50 Cr. The company has closed loans amounting to ₹1.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tanya Jain and Sakshi Jain serve as directors at the Company.
- CIN/LLPIN
U24231UP1986PTC007695
- Company No.
007695
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 1986
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cosy Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tanya Jain  | Additional Director | Current | |
| Sakshi Jain | Director | 15-Apr-2021 | Current |
Financial Performance and Corporate Structure Insights of Cosy Pharmaceuticals.
Cosy Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 62.22% decrease in profit. The company's net worth dipped by a decrease of 0.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosy Pharmaceuticals?
In 2023, Cosy Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rajhans Enterprises Private LimitedActive 11 years 11 monthsTanya Jain and Sakshi Jain are mutual person
Shivangi Remedies Private LimitedActive 28 years 5 monthsTanya Jain and Sakshi Jain are mutual person
- Shivangi Credits Private LimitedActive 28 years 3 months
Tanya Jain and Sakshi Jain are mutual person
- Jenson Healthcare Private LimitedActive 37 years 9 months
Tanya Jain and Sakshi Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 31 Oct 2008 | ₹19.50 Cr | Open |
Punjab National Bank Creation Date: 09 Oct 2003 | ₹1.20 Cr | Satisfied |
Punjab National Bank Creation Date: 15 Apr 1999 | ₹1.50 M | Satisfied |
How Many Employees Work at Cosy Pharmaceuticals?
Unlock and access historical data on people associated with Cosy Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosy Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
